Protein-based matrix interferences in ligand-binding assays.

Protein-based matrix interferences in ligand-binding assays.

Item
http://www.wikidata.org/entity/Q38211931
Emerging Technologies and Generic Assays for the Detection of Anti-Drug Antibodies.Standardizing terms, definitions and concepts for describing and interpreting unwanted immunogenicity of biopharmaceuticals: recommendations of the Innovative Medicines Initiative ABIRISK consortiumHigh Estradiol Levels During Postmenopause - Pitfalls in Laboratory Analysis.Pre-existing Antibody: Biotherapeutic Modality-Based Review.Parallelism experiments to evaluate matrix effects, selectivity and sensitivity in ligand-binding assay method development: pros and cons.Qualitative and quantitative characterization of protein biotherapeutics with liquid chromatography mass spectrometry.Bypassing nonparallelism of a monoclonal antibody ligand-binding assay by employment of alternative assay formats.Overcoming disease-specific matrix effect in a clinical pharmacokinetic assay using a microfluidic immunoassay technology.
P2860

Protein-based matrix interferences in ligand-binding assays.

Item
http://www.wikidata.org/entity/Q38211931
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Protein-based matrix interferences in ligand-binding assays.
@en
type
label
Protein-based matrix interferences in ligand-binding assays.
@en
prefLabel
Protein-based matrix interferences in ligand-binding assays.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Protein-based matrix interferences in ligand-binding assays
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921